Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Petra Votavova

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Immunology Letters|February 12, 2014
Increasing the biological activity of IL-2 and IL-15 through complexing with anti-IL-2 mAbs and IL-15Rα-Fc chimeraPetra Votavova, Jakub Tomala, Marek Kovar
Journal of Biomedical Nanotechnology|October 22, 2015
Novel IL-2-Poly(HPMA)Nanoconjugate Based ImmunotherapyPetra Votavova, Jakub Tomala, Vladimir Subr, et al.
ACS Chemical Biology|February 20, 2013
Chimera of IL-2 linked to light chain of anti-IL-2 mAb mimics IL-2/anti-IL-2 mAb complexes both structurally and functionallyJakub Tomala, Jirina Kovarova, Martina Kabesova, et al.
Immunity|May 21, 2015
Antibodies to Interleukin-2 Elicit Selective T Cell Subset Potentiation through Distinct Conformational MechanismsJamie B Spangler, Jakub Tomala, Vincent C Luca, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 2018
Engineering a Single-Agent Cytokine/Antibody Fusion That Selectively Expands Regulatory T Cells for Autoimmune Disease TherapyJamie B Spangler, Eleonora Trotta, Jakub Tomala, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Immunology Letters|February 12, 2014
Increasing the biological activity of IL-2 and IL-15 through complexing with anti-IL-2 mAbs and IL-15Rα-Fc chimeraPetra Votavova, Jakub Tomala, Marek Kovar
Journal of Biomedical Nanotechnology|October 22, 2015
Novel IL-2-Poly(HPMA)Nanoconjugate Based ImmunotherapyPetra Votavova, Jakub Tomala, Vladimir Subr, et al.
ACS Chemical Biology|February 20, 2013
Chimera of IL-2 linked to light chain of anti-IL-2 mAb mimics IL-2/anti-IL-2 mAb complexes both structurally and functionallyJakub Tomala, Jirina Kovarova, Martina Kabesova, et al.
Immunity|May 21, 2015
Antibodies to Interleukin-2 Elicit Selective T Cell Subset Potentiation through Distinct Conformational MechanismsJamie B Spangler, Jakub Tomala, Vincent C Luca, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 2018
Engineering a Single-Agent Cytokine/Antibody Fusion That Selectively Expands Regulatory T Cells for Autoimmune Disease TherapyJamie B Spangler, Eleonora Trotta, Jakub Tomala, et al.
Pageof 1